Company intelligence / Profile preview
Quigley Pharma Inc.
Doylestown, Pennsylvania, United Statesbiospace.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Quigley Pharma conducted research on natural-source prescription medicinals. It had conducted one positive pre-clinical in vitro study on Avian Flu, demonstrating antiviral activity. The company was working on products for conditions such as diabetic peripheral neuropathy, radiation dermatitis, and influenza.
- Therapeutic areas
- EndocrinologyDermatologyOtherOncologyNeurologyInfectious Diseases
- Modalities
- Natural-source prescription medicinals
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Quigley Pharma Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Quigley Pharma Inc..